Globus Medical Reports Third Quarter 2026 Results and Announces Share Repurchase Program Increase

Globus Medical reported third-quarter 2026 worldwide net sales of $763.7 million, down 0.7% year over year. GAAP net income was $141.2 million, with diluted EPS of $1.04, up 18.2%; non-GAAP diluted EPS rose 4.4% to $1.23. The company increased its share repurchase program by $500 million and lowered its 2026 revenue guidance to $3.09 billion from $3.18 billion–$3.22 billion, while reaffirming non-GAAP diluted EPS guidance of $4.95–$5.05.